FDA inspection
Adimmune Corporation: FDA inspection ending Nov 21, 2023
FDA inspection 1223867 · Voluntary Action Indicated (VAI) · Taichung City
Key facts
| Inspection ID | 1223867 |
|---|---|
| Firm | Adimmune Corporation |
| FEI number | 3008919998 |
| Address | No. 3 Tanxing Rd., Sec. 1, Tanzi Dist. |
| City | Taichung City |
| Country | Taiwan |
| Fiscal year | 2024 |
| Inspection end date | Nov 21, 2023 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Vaccines and Allergenic Products |
| Product type | Biologics |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data